A Phase I Study of Neihulizumab (AbGn-168H) in Patients

Project: Research project

Project Details

Description

A Phase I Study of Neihulizumab (AbGn-168H) in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease (sr-aGvHD)
StatusActive
Effective start/end date3/1/183/1/22

Funding

  • ABGENOMICS INTERNATIONAL INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.